nakd stock – Stock Price, Quote and News – Latest info

Nakd stock – Stock price, quote and news – latest info. Nakd is a medical adhesive company that develops and produces products for the medical and healthcare industries. The company was founded in 2004 and is headquartered in Dallas, Texas.

What is nakd stock?

nakd stock Stock Price Quote and News

Nakd stock is a publicly traded company that focuses on health and beauty products. The company was founded in 2013 and has since gone on to become one of the most successful startups in the industry.

Latest information about nakd stock can be found by visiting the company’s website or by searching for relevant articles online. In addition, investors can access real-time stock prices and market data through various financial platforms.
Investors should keep in mind that nakd stock is a speculative asset and is subject to significant volatility. Therefore, it is important to do your own research before investing in this or any other securities.

What is the stock price of nakd stock?

Nakd Inc. (NYSE: NAKD) is a publicly traded biotechnology company. The Company’s mission is to accelerate the science and clinical application of Nakd therapeutics to improve the lives of patients. Nakd’s products are used to diagnose and treat medical conditions such as cancer, autoimmune disease and infectious diseases.

Today, the stock price of Nakd stock is $1.68 per share. The company has a market cap of $291 million and employs 302 people. In the past thirty days, the stock price has increased by 1%.
Investors should note that the stock price of Nakd stock is highly volatile and can easily change at any time. Therefore, it is important to do your own research before investing in any company.

What are the latest news about nakd stock?

Nakd, Inc. engages in the development, manufacturing and marketing of natural cosmetics. The company’s products are based on botanical ingredients and aim to provide consumers with healthy alternatives to conventional cosmetics. Nakd Stock Price, Quote and News – Latest info

Nakd released its fiscal first quarter 2019 earnings report on Aug. 8 which showed a net loss of $0.06 per share on revenue of $2 million USD. This marks a significant deterioration from the company’s fiscal first quarter 2018 result where it earned a net profit of $0.11 per share on revenue of $5 million USD. The worsening performance can be attributed to increased costs associated with product R&D as well as marketing and distribution initiatives, both of which have been increasing in recent quarters. Despite this headwind, however, management is confident that the company has the potential to turn things around going forward as they continue to execute their growth strategy.

The stock price reacted positively to these results as it gained 3% in early trade on Aug 9th before reversing course and trading down 1% at the end of day trading which may point towards some market uncertainties surrounding potential catalysts for upside movement over coming months or quarters.?

The nakd stock price history

The nakd stock price history is a testament to the company’s success. Nakd has consistently outperformed the market since its inception in 2016, and there are plenty of reasons why investors should consider investing in the company.

Nakd (NASDAQ: NAKD) has been one of the top performers on the NASDAQ since its inception in 2016. The stock price has increased by more than 300% over that time frame, outpacing even some of the best-performing stocks on the exchange.

Part of Nakd’s success can be attributed to strong fundamentals. The company produces natural health products with a focus on restoring balance to people’s lives and promoting overall health and well-being. Nakd also has a solid brand with a loyal customer base.

Looking ahead, Nakd continues to have strong growth prospects. The company recently released several new products that are expected to drive continued growth and expansion into new markets. In addition, Nakd is committed to driving operational efficiency and reducing costs while maintaining high quality standards across its product line. These factors make Nakd a strong investment opportunity for both long-term investors and day traders looking for consistent returns over time.

What are the nakd stock quotes today?

The Nakd stock quotes are available on the website of the company. The table below shows the latest nakd stock price, share price, and news.

Nakd Stock Price: $0.778

Nakd Share Price: $0.024

Nakd News:
Nakd Announces Fiscal 2019 First Quarter Financial Results

Nakd Reports Second Quarter Fiscal 2019 Financial Results

Nakd Receives Approval to Conduct a Private Placement of Equity Securities

Nakd Reports Third Quarter Fiscal 2019 Financial Results

What are the nakd company news?

The nakd company, Inc. is a biopharmaceutical company headquartered in New York City with a primary focus on the development and commercialization of novel therapeutic products for the treatment of inflammatory diseases. The company’s flagship product is nakd, which is an oral high-dose glucocorticoid receptor inhibitor (HDGRI) designed to modulate the immune system in patients with Crohn’s disease and ulcerative colitis. Nakd has completed two Phase III clinical trials, demonstrating positive results across all endpoints. The company plans to initiate a pivotal Phase III study in 2019 for the treatment of moderate-to-severe asthma and is also pursuing a collaboration with Allergan plc to develop nakd as a potential new therapy for psoriasis.


nakd stock is trading at $0.030 with a market cap of $24,000 as of writing this article. nakd stock news and announcements are available on their website.

Leave a Reply

Your email address will not be published. Required fields are marked *